Magic Valley Kidney Center is a medicare approved dialysis facility center in Twin Falls, Idaho and it has 18 dialysis stations. It is located in Twin Falls county at 350 N Haven Dr Ste 100, Twin Falls, ID, 83301. You can reach out to the office of Magic Valley Kidney Center at (208) 735-3914. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Magic Valley Kidney Center has the following ownership type - Profit. It was first certified by medicare in February, 2014. The medicare id for this facility is 132526 and it accepts patients under medicare ESRD program.
| Name | Magic Valley Kidney Center |
|---|---|
| Location | 350 N Haven Dr Ste 100, Twin Falls, Idaho |
| No. of Dialysis Stations | 18 |
| Medicare ID | 132526 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 350 N Haven Dr Ste 100, Twin Falls, Idaho, 83301 | |
| (208) 735-3914 | |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
| NPI Number | 1154669695 |
| Organization Name | Magic Valley Dialysis Center |
| Doing Business As | Tfld Partners, Llc |
| Address | 350 North Haven Drive Twin Falls, Idaho, 83301 |
| Phone Number | (206) 236-5001 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 16 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 25 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 37 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 243 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
| Adult patients getting regular peritoneal dialysis at the center | 25 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 171 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 95 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Magic Valley Kidney Center with elevated calcium levels.
| Patients with hypercalcemia | 61 |
| Hypercalcemia patient months | 450 |
| Patients with Serumphosphor | 69 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 35 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 17 |
| Patients with Serumphosphor greater than 7 mg/dL | 7 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 40 |
| Patient months included in arterial venous fistula and catheter summaries | 209 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 64 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 39 |
| Hospitalization Rate in facility | 170.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 334.3 |
| Hospitalization Rate: Lower Confidence Limit | 91.6 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Magic Valley Kidney Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.7 |
| Readmission Rate: Lower Confidence Limit | 18.9 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Magic Valley Kidney Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.45 (As Expected) |
| SIR: Upper Confidence Limit | 3.95 |
| SIR: Lower Confidence Limit | .37 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Magic Valley Kidney Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 36 |
| Transfusion Rate in facility | 24.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 118.6 |
| Transfusion Rate: Lower Confidence Limit | 6.1 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Magic Valley Kidney Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 115 |
| Mortality Rate in facility | 26.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 43 |
| Mortality Rate: Lower Confidence Limit | 15.7 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago
Magic Valley Kidney Center Location: 350 N Haven Dr Ste 100, Twin Falls, Idaho, 83301 Phone: (208) 735-3914 |
News Archive
The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).
Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.
› Verified 7 days ago